92 related articles for article (PubMed ID: 2582838)
21. Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma.
Bauer K; Dietersdorfer F; Sertl K; Kaik B; Kaik G
Clin Pharmacol Ther; 1993 Jan; 53(1):76-83. PubMed ID: 8422745
[TBL] [Abstract][Full Text] [Related]
22. Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma.
Burgess CD; Windom HH; Pearce N; Marshall S; Beasley R; Siebers RW; Crane J
Am Rev Respir Dis; 1991 Feb; 143(2):444-6. PubMed ID: 1671326
[TBL] [Abstract][Full Text] [Related]
23. Optimal dose of fenoterol by metered-dose inhaler in asthmatic adults.
Conrad SA; Light RW; George RB
Chest; 1986 Mar; 89(3):394-7. PubMed ID: 3512188
[TBL] [Abstract][Full Text] [Related]
24. The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma.
Windom HH; Burgess CD; Siebers RW; Purdie G; Pearce N; Crane J; Beasley R
Clin Pharmacol Ther; 1990 Sep; 48(3):296-301. PubMed ID: 1976051
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular effects of theophylline. Partial attenuation by beta-blockade.
Conrad KA; Prosnitz EH
Eur J Clin Pharmacol; 1981; 21(2):109-14. PubMed ID: 6122579
[TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular effect of fenoterol (Partusisten)].
Retzke U; Schwarz R; Wilken HP
Zentralbl Gynakol; 1977; 99(22):1371-6. PubMed ID: 602506
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
[TBL] [Abstract][Full Text] [Related]
28. The effects of oral doses of theophylline and fenoterol on exercise-induced asthma.
Eggleston PA; Beasley PP; Kindley RT
Chest; 1981 Apr; 79(4):399-405. PubMed ID: 7226903
[TBL] [Abstract][Full Text] [Related]
29. Interaction between corticosteroid and beta-agonist drugs. Biochemical and cardiovascular effects in normal subjects.
Taylor DR; Wilkins GT; Herbison GP; Flannery EM
Chest; 1992 Aug; 102(2):519-24. PubMed ID: 1353717
[TBL] [Abstract][Full Text] [Related]
30. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
Grove A; Lipworth BJ
Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
[TBL] [Abstract][Full Text] [Related]
31. beta-agonistic bronchodilators: comparison of dose/response in working rat hearts.
Zimmer G; Dahinten A; Fitzner A; Halbig S; Noll T; Treusch F; Libertus H
Chest; 2000 Feb; 117(2):519-29. PubMed ID: 10669699
[TBL] [Abstract][Full Text] [Related]
32. Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline.
Whyte KF; Reid C; Addis GJ; Whitesmith R; Reid JL
Br J Clin Pharmacol; 1988 May; 25(5):571-8. PubMed ID: 3408637
[TBL] [Abstract][Full Text] [Related]
33. [Effects of fenoterol on blood pressure, heart rate, and cardiotocogram of hypertensive and normotensive women in advanced pregnancy (author's transl)].
Oddoy A; Joschko K
Zentralbl Gynakol; 1982; 104(7):415-21. PubMed ID: 7102159
[TBL] [Abstract][Full Text] [Related]
34. A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.
Karpel JP; Kotch A; Zinny M; Pesin J; Alleyne W
Chest; 1994 Apr; 105(4):1089-94. PubMed ID: 8162730
[TBL] [Abstract][Full Text] [Related]
35. [Cardiac tolerance of a beta 2-sympathomimetic spray in 37 asthmatic adults monitored by Holter recording].
Migueres J; Escamilla R; Longhi R; Hermant C; Massabuau P; Bounhoure JP; Keita B
Allerg Immunol (Paris); 1987 Mar; 19(3):104-9. PubMed ID: 3135819
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular effects of enprofylline and theophylline.
Esquivel M; Burns RJ; Ogilvie RI
Clin Pharmacol Ther; 1986 Apr; 39(4):395-402. PubMed ID: 3956056
[TBL] [Abstract][Full Text] [Related]
37. Indices of cardiac function during treatment with betamimetic drugs (fenoterol and hexoprenaline).
Siekmann U; Heilmann L; Irmer M
Arch Gynecol; 1983; 233(2):73-83. PubMed ID: 6882019
[TBL] [Abstract][Full Text] [Related]
38. The uterine and cardiovascular effects of oral fenoterol hydrobromide.
Lipshitz J
Br J Obstet Gynaecol; 1977 Oct; 84(10):737-9. PubMed ID: 921909
[TBL] [Abstract][Full Text] [Related]
39. Role of exogenous adenosine as a modulator of theophylline toxicity.
Ujhelyi MR; Hulula G; Skau KA
Crit Care Med; 1994 Oct; 22(10):1639-46. PubMed ID: 7924377
[TBL] [Abstract][Full Text] [Related]
40. Effects of inhaled oxitropium and fenoterol, alone and in combination, in chronic airflow obstruction.
Frith PA; Jenner B; Atkinson J
Respiration; 1986; 50 Suppl 2():294-7. PubMed ID: 3563116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
